Strouhalova, K., Přechová, M., Gandalovičová, A., Brábek, J., Gregor, M. and Rosel, D. (2020) Vimentin Intermediate Filaments as Potential Target for Cancer Treatment. Cancers, 12, Article No. 184.
https://doi.org/10.3390/cancers12010184

has been cited by the following article:

• TITLE: Analysis of Differential Gene Expression and Core Canonical Pathways Involved in the Epithelial to Mesenchymal Transition of Triple Negative Breast Cancer Cells by Ingenuity Pathway Analysis

  AUTHORS: Elizabeth Cagle, Brent Lake, Anasua Banerjee, Jazmine Cuffee, Narendra Banerjee, Darla Gilmartin, Makaiyah Liverman, Shennel Brown, Erik Armstrong, Santanu Bhattacharya, Somiranjan Ghosh, Tanmoy Mandal, Hirendra Banerjee

  KEYWORDS: Triple Negative Breast Cancer, Epithelial to Mesenchymal Transition, Core Canonical Pathways

  JOURNAL NAME: Computational Molecular Bioscience, Vol.13 No.2, May 19, 2023

  ABSTRACT: Triple Negative Breast Cancer (TNBC) is a malignant form of cancer with very high mortality and morbidity. Epithelial to Mesenchymal Transition (EMT) is the most common pathophysiological change observed in cancer cells of epithelial origin that promotes metastasis, drug resistance and cancer stem cell formation. Since the information regarding differential gene expression in TNBC cells and cell signaling events leading to EMT is limited, this investigation was done by comparing transcriptomic data generated by RNA isolation and sequencing of a EMT model TNBC cell line in comparison to regular TNBC cells. RNA sequencing and Ingenuity Pathway Software Analysis (IPA) of the transcriptomic data revealed several upregulated and downregulated gene expressions along with novel core canonical pathways including Sirtuin signaling, Oxidative Phosphorylation and Mitochondrial dysfunction events involved in EMT changes of the TNBC cells.